Journals
Topics
Contributed Content
August 21, 2017
August 20, 2017
August 16, 2017
Latest News
August 21, 2017 | Mary Caffrey
More work needs to be done before this discovery can be translated into a therapeutic solution, but researchers have gained insights into why some people become infected with a pathogen and others don't.
August 21, 2017 | Surabhi Dangi-Garimella, PhD
High out-of-pocket (OOP) medical costs in survivors of childhood cancer can influence their treatment choices and care-related behavior, and ultimately affect their health outcomes, according to a study published in the Journal of Clinical Oncology.
August 21, 2017 | Christina Mattina
A CDC study asked adolescents and adults about their contact lens practices and found that most reported engaging in at least 1 risky behavior.
August 21, 2017 | AJMC Staff
August 21, 2017 | Christina Mattina
As observers across the United States prepare to witness a rare solar eclipse this afternoon, ophthalmologists are making sure the importance of vision safety is not overshadowed by the excitement.
August 21, 2017 | Alison Rodriguez
The FDA has approved Besponsa (inotuzumab ozogamicin) for treating adults with relapsed or refractory B-cell precursor acute lymphoblastic leukemia.
August 20, 2017 | Alison Rodriguez
New report from America's Health Insurance Plans outlines how negative social determinants of health are being addressed by federal and state agencies.
August 20, 2017 |
Employers understand what accountable care organizations are, but they need a better understanding of how they deliver value better than the market, explained Brian Marcotte, president and CEO of the National Business Group on Health
August 20, 2017 | Alison Rodriguez
Among wealthy countries, the United States maintains the most substantial socioeconomic disparities in access to healthcare; however, these disparities were reduced when the Affordable Care Act (ACA) was implemented, according to a new study in Health Affairs.
August 19, 2017 | Alison Rodriguez
Study assessed the patterns of care for biologic-dosing outliers and nonoutliers in patients with rheumatoid arthritis.
August 19, 2017 |
Every week, The American Journal of Managed Care® recaps the top managed care news of the week, and you can now listen to it on our podcast, Managed Care Cast.
August 19, 2017 | Alison Rodriguez
Researchers can determine the best treatments for skin disorders, like atopic dermatitis and ringworm, by first observing how they benefit pets with the same conditions.
August 18, 2017 | Surabhi Dangi-Garimella, PhD
A new oral dosage form of olaparib (Lynparza) has been approved as maintenance treatment in women with recurrent epithelial ovarian, fallopian tube, or primary peritoneal cancer, who are in a complete or partial response to platinum-based chemotherapy.
August 18, 2017 | Alison Rodriguez
Patient preferences for multiple sclerosis therapies are important to take into account and are increasingly so as alternatives to traditional injection therapies are developed to address adherence issues.
From the Journals
Cai et al
The Hospital-in-Home program implemented at the Veterans Affairs Pacific Islands Health Care System in Honolulu, Hawaii, is associated with reduced costs with no compromise in quality.
Keteyian et al
Technology innovation drives expenditures. A Michigan Medicine, IBM, and AirStrip partnership demonstrates the hospital’s role in developing transformative technologies that deliver value.
Parikh et al
In a multicenter cohort of patients with newly diagnosed pulmonary hypertension, increased risk for mortality among African Americans was no longer observed after adjusting for insurance status.
Kaplan
A community oncologist's perspective on the advantages and challenges with precision medicine.
Perfetto
A reaction to Institute for Clinical and Economic Review's value assessment framework by Eleanor M. Perfetto, PhD, MS, of The National Health Council.
Dangi-Garimella
Syapse improves patient outcomes by providing workflow solutions that enable cancer care providers to deliver precision medicine within their organization, Ken Tarkoff, the company's CEO, told Evidence-Based Oncology™.
Fitzpatrick
Collaborating with diverse stakeholders, including the FDA and the Surveillance, Epidemiology, and End Results program, CancerLinQ continues its efforts to harness big data to rapidly improve the quality of care for people with cancer.
Haidle et al
Genetic counselors (GCs) increasingly serve a variety of roles across the healthcare spectrum, including test utilization management. Our data show that utilizing the expertise of GCs reduced test order errors, improved patient outcomes, and resulted in significant cost savings to the healthcare system.
Alvarnas
As we shift to the precision-medicine model of cancer care, it is essential to develop a scalable system that can deliver these care solutions in a patient-centered, economically sustainable way.
Compendia
Know Your News
Formulary
Upcoming Partner Events
Most Popular
Interviews View More Interviews >>
AJMC Strategic Alliance
